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Abstract The neurotrophins Ngf, Bdnf, NT-3, NT4–5
have key roles in development, survival, and plasticity of
neuronal cells. Their action involves broad gene expression
changes at the level of transcription and translation. Mi-
croRNAs (miRs)—small RNA molecules that control gene
expression post-transcriptionally—are increasingly impli-
cated in regulating development and plasticity of neural
cells. Using PC12 cells as a model system, we show that
Ngf modulates changes in expression of a variety of mi-
croRNAs, including miRs known to be modulated by
neurotrophins—such as the miR-212/132 cluster—and
several others, such as miR-21, miR-29c, miR-30c, miR-
93, miR-103, miR-207, miR-691, and miR-709. Pathway
analysis indicates that Ngf-modulated miRs may regulate
many protein components of signaling pathways involved
in neuronal development and disease. In particular, we
show that miR-21 enhances neurotrophin signaling and
controls neuronal differentiation induced by Ngf. Notably,
in a situation mimicking neurodegeneration—differenti-
ated neurons deprived of Ngf—this microRNA is able to
preserve the neurite network and to support viability of the
neurons. These findings uncover a broad role of microR-
NAs in regulating neurotrophin signaling and suggest that
aberrant expression of one or more Ngf-modulated miRs
may be involved in neurodegenerative diseases.
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Introduction
Neurotrophins—nerve growth factor (Ngf), brain-derived
neurotrophic factor (Bdnf), neurotrophin 3 (NT3), and neu-
rotrophin 4–5 (NT4–5)—are a family of growth factors that
regulate neuronal development, survival, synapse formation,
and plasticity (Chao et al. 2006). They act through multiple
mechanisms triggered upon binding to two kinds of cell sur-
face receptors: a Trk tyrosine kinase receptor, specific for the
single neurotrophins—TrkA, B, C—and the p75 neurotrophin
receptor, bound by all of them (Kaplan and Miller 2000).
Binding to Trk receptors activates intracellular signaling
pathways—including extracellular signal-regulated kinase/
mitogen-activated protein kinase (ERK/MAPK), phosphoin-
ositide 3-kinase (Pi3K), and phospholipase C (PLC) path-
ways—that lead to phosphorylation of transcription factors
like Creb and trigger changes in the expression of hundreds
mRNAs encoding proteins such as c-Fos, Tyrosine Hydrox-
ylase, Vgf, Bcl-2 (Kaplan and Miller 2000; Annibali and Nasi
2007). Increasing evidence of the implication of miRs in
differentiation and plasticity of neurons (Kosik 2006), sug-
gests that transcriptional regulation of miR expression may
represent a relevant mechanism mediating neurotrophin
functions (Vo et al. 2005; Remenyi et al. 2010; Terasawa et al.
2006). The clearest example is transcriptional regulation of
the miR-212/132 cluster by Bdnf via ERK/MAPK signaling
and Creb phosphorylation (Vo et al. 2005; Remenyi et al.
2010; Wanet et al. 2012). Mir-212 and miR-132 have roles in a
variety of processes including neuronal differentiation, den-
dritic arborization, synaptic plasticity, and cognitive processes
(Tognini et al. 2011; Luikart et al. 2011). Their deregulation is
associated with brain-related diseases, such as schizophrenia
(Miller and Wahlestedt 2012), bipolar disorder, neurodegen-
erative diseases (Wanet et al. 2012).
Ngf—the prototype neurotrophin—has a role in peripheral
and central nervous system neurons, such as forebrain cho-
linergic neurons. Ngf signaling defects have been implicated
in aging and Alzheimer’s disease (AD) (Calissano et al. 2010;
Matrone et al. 2008a, b). To investigate miR expression in
response to Ngf, we have employed the PC12 pheochromo-
cytoma cell line, a model for the Ngf action mechanism. PC12
cells respond to Ngf by differentiating into cholinergic neu-
rons and were shown to reproduce certain aspects of the
molecular mechanism underlying neurodegeneration in AD
(Matrone et al. 2008b). Here, we report the identification of a
variety of microRNAs whose expression is modulated by Ngf.
We show that the microRNAs have the potential to control
several aspects of neuronal development, plasticity, and dis-
ease. We report that miR-21—one of the Ngf-modulated
miR—regulates Ngf signaling, mediates neuronal differentia-
tion, and prevents neurodegeneration triggered by Ngf removal.
Results
Ngf Controls miR Expression in PC12 Cells
To identify microRNAs differentially expressed upon Ngf
treatment of naive PC12 cells or upon Ngf deprivation of ter-
minally differentiated cells, we isolated total RNA from PC12
cells: unstimulated, treated with Ngf for 1, 3, 6, 24 h, 10 days,
or deprived of Ngf for 24 h after 10 days of treatment with Ngf.
We profiled miR expression by a miRCURY LNATM Array
containing over 500 unique miRs and spike-in controls. We
normalized microarray expression data with the LOWESS
algorithm, and took into account only miRs showing signals
significantly higher than background. To compute fold chan-
ges, we compared signal intensities of cells treated with Ngf for
different times to those of untreated cells. We evaluated differ-
ential expression according to the following two criteria: (1) a
fold change (FC) of at least 1.7 in absolute value and (2) a
p value B 0.05. Treatment with Ngf resulted in the upregula-
tion of 68 and downregulation of 44 miRs (Table S1). Raising
the FC threshold to two, only 30 miRs appeared to be upregu-
lated and 24 repressed. A small number of microRNAs are
modulated at 1–3 h of Ngf treatment: miR-709, -665, -299-3p,
-33, -33a, -29c, -130a, miR-691 and few others (Table S1 A, B).
The pattern of Ngf-modulated miRs becomes quite complex at
24 h and 10 days of treatment (Table S1 D, E). Early-modulated
miRs are expected to be more directly linked to Ngf signaling.
Among them, miR-299-3p, miR-709, miR-665, miR-691 were
upregulated at early time points—they were no longer upreg-
ulated or they were repressed later on—whereas miR-29c, miR-
33a, and miR-130a were transiently repressed. MiR-21 and
miR-207 were upregulated from 6 h to 10 days (Table S1 C, E).
Data are accessible at the Gene Expression Omnibus web site
(The Gene Expression Omnibus 2013), DataSet GSE46827.
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Ngf-modulated miRs Affect Neuronal Signaling
Pathways
The transcription factor Creb is a key mediator of neuro-
trophin signaling (Kaplan and Miller 2000; Annibali and
Nasi 2007). To assess its involvement in controlling the
expression of Ngf-modulated miRs, we investigated the
presence of Creb binding sites at their promoters. We
employed the JASPAR web site (JASPAR 2013) to inter-
rogate the database of microRNA promoters validated by
chromatin immunoprecipitation (Marson et al. 2008). We
found a statistically significant enrichment of Creb binding
sites at promoters of microRNAs modulated at 3, 6, and
24 h of Ngf treatment, compared with a random promoter
population (data not shown). This supports the hypothesis
that Ngf may control the expression of early-modulated
miRs, at least in part, via Creb.
To get an insight into the possible function of the miRs
modulated by Ngf, we made use of DIANA LAB—DNA
Intelligent Analysis software (DIANA LAB 2013) to
retrieve their predicted targets, and we identified the path-
ways affected by their expression by means of the KEGG
PATHWAY database (KEGG PATHWAY 2013). We
retained only pathways with p values B0.05, calculated by
the hypergeometric distribution. Targets of miRs modulated
at 1 h were mainly involved in signaling pathways con-
cerning differentiation, proliferation, survival, cell adhesion,
TGF-beta signaling, neurotrophin signaling, JAK-STAT
signaling, and extracellular matrix (ECM)—receptor inter-
action (Table 1). Predicted targets of microRNAs modulated
by Ngf at 3 and 6 h were preferentially enriched in signaling
pathways—MAPK, TGF-beta, p-53 signaling, ECM-recep-
tor interaction—long-term depression, focal adhesion,
adherens junction, axon guidance, and glioma. Targets of
miRs modulated at 24 h were involved in axon guidance,
MAPK signaling, and long-term depression. Targets of miRs
modulated at 10 days were strongly enriched in axon guid-
ance, MAPK signaling, and long-term depression pathways.
This strongly suggests that several Ngf-modulated miRs may
have a role in Ngf signaling.
Validation of Array Data by Real-Time PCR
To validate by quantitative real-time PCR (RT-PCR) miR
differential expression upon Ngf treatment, we focused on a
set of ten microRNAs, chosen for expression pattern,
experimentally proven targets, and literature data. Seven of
them—miR-21, miR-29c, miR-30c, miR-93, miR-207, miR-
691, miR-709—were picked from the list in Fig. 1. The
remaining three microRNAs—miR-103, miR-212, and miR-
132—are not listed in Fig. 1 since they presented a sub-
threshold modulation by Ngf in the array experiments (data
not shown), but were selected for the following reasons.
Expression of the miR-212/132 cluster in cortical and hip-
pocampal neurons is induced by Bdnf through Creb and their
promoter is bound by Creb in PC12 cells (Vo et al. 2005;
Remenyi et al. 2010). The two microRNAs are implicated in
synaptic plasticity, mental diseases, and drug dependence
(Impey et al. 2010; Im et al. 2010). The deregulation of the
miR-212/132 cluster correlates with neurological disorders
such as AD and tauopathies (Wanet et al. 2012). MiR-103 is
induced during differentiation of neuroblastoma cells
Table 1 MicroRNAs modulated by Ngf appear to be involved in cell
signaling
KEGG Pathway p value #genes #miRNAs
A 1 h Ngf
TGF-beta signaling pathway \0.01 15 6
Neurotrophin signaling pathway \0.01 17 6
Circadian rhythm 0.02 5 5
ECM-receptor interaction 0.02 6 3
SNARE interactions in vesicular
transport
0.02 6 6
JAK-STAT signaling pathway 0.02 18 8
B 3 h Ngf
Long-term depression 0.02 9 5
MAPK signaling pathway 0.02 24 5
Focal adhesion 0.04 19 5
TGF-beta signaling pathway 0.04 11 4
C 6 h Ngf
ECM-receptor interaction \0.01 9 4
Focal adhesion \0.01 24 7
Axon guidance 0.02 14 6
TGF-beta signaling pathway 0.04 10 6
Adherens junction 0.04 9 6
D 24 h Ngf
Axon guidance \0.01 30 8
MAPK signaling pathway 0.04 43 7
Long-term depression 0.04 13 6
E 240 h Ngf
TGF-beta signaling pathway \0.01 50 39
Wnt signaling pathway \0.01 89 41
Axon guidance \0.01 74 41
Neurotrophin signaling pathway \0.01 72 44
Focal adhesion \0.01 103 40
Long-term potentiation \0.01 42 40
ErbB signaling pathway \0.01 48 39
MAPK signaling pathway 0.02 125 43
Predicted targets of all microRNAs modulated by Ngf at each time
point—from 1 to 240 h—were retrieved and mapped into the KEGG
Pathway database through DIANA miR-Path software; only pathways
with p value B 0.05 were retained. Pathways relevant to nervous
system and neurons are shown; the number of Ngf-modulated miRs
targeting a given pathway and the numbers of genes that are targeted
in that pathway are also indicated
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Fig. 1 MicroRNAs modulated
by Ngf in PC12 cells.
Expression values of
microRNAs modulated by Ngf
are represented as heat map.
The left image (?Ngf) shows
microRNAs differentially
expressed in PC12 cells at 1, 3,
6, 24 h and 10 d of Ngf
treatment, relative to cells
untreated with Ngf. The image
on the right (Ngf deprivation)
refers to microRNA expression
in PC12 cells that were treated
with Ngf for 10 days and then
deprived of Ngf for 24 h,
relative to cells treated with Ngf
for 10 days but not deprived of
Ngf. Only microRNAs
modulated by Ngf in at least one
condition are shown. Red and
green indicate, respectively,
increased or decreased
expression relative to controls;
black indicates no expression
change; gray indicates that
microRNA expression was
undetected. Only miR
expression values satisfying the
threshold criteria—p value
B0.05 in two-tailed Student’s
t test; fold change B-1.7 or
C1.7—are reported
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(Annibali et al. 2012), has several targets in neurotrophin
signaling and MAPK pathways, and has been implicated in
AD (Yao et al. 2010). We compared RNA samples extracted
from untreated cells with samples extracted from PC12 cells
stimulated with Ngf for the same periods as in the array
experiments—1, 3, 6, 24 h and 10 days of treatment—as
well as from cells deprived of Ngf for 24 h after 10 days of
treatment with Ngf (Fig. 2). We found a significant corre-
lation between microarray and RT-PCR data as regards
differential expression of the seven miRs picked from the list
of Ngf-modulated microRNAs. MiR-212 and miR-132
expression as well was modulated by Ngf, as expected for
their responsiveness to Bdnf and Creb (Vo et al. 2005;
Remenyi et al. 2010). The amount of miR-212 increased
starting at 3 h of Ngf exposure and remained higher than
control for all successive time points (6, 24 h, 10 days).
After 24 h of Ngf treatment, we observed a significant miR-
132 increase, still detectable at 10 days. The increased
expression levels of the ten miRs appeared to be sustained by
ongoing Ngf signaling, since they all returned to a level
comparable to naive cells upon deprivation of Ngf for 24 h
(Fig. 2). Among them, miR-21 and miR-29c were less
sensitive to deprivation of Ngf. This suggests that Ngf has a
transient effect upon expression of all these miRNAs in PC12
cells.
To gain an insight into the possible function of the RT-PCR
validated microRNAs, we made use of DIANA microT
(http://diana.cslab.ece.ntua.gr/microT/) to retrieve putative
targets of the set of ten miRs and map them to pathways as
described above (Table 2A). The set of their targets was sig-
nificantly enriched in neurotrophin, MAPK, Akt, mTOR, and
TGF-beta signaling pathways as well as in ECM-receptor
interaction, axon guidance, focal adhesion, gap junction, and
long-term depression, in accordance with Table 1 data.
We then retrieved predicted targets of each single micr-
oRNA with TargetScan and mapped them to KEGG Pathway
(Table 2B). We focused on nervous system related pathways
and we considered only pathways with p values B0.05. We
found over representation of a variety of signaling path-
ways—Pi3K/Akt, MAPK, neurotrophin, and Wnt signal-
ing—synaptic pathways—glutamergic, dopaminergic,
cholinergic, GABA-ergic synapses—and pathways of axon
guidance, cell adhesion, long-term potentiation, and AD. A
single pathway component was frequently hit by different
Fig. 2 Expression analysis of select microRNAs upon Ngf induction.
a The plots show the amounts of each of the ten select miRs (21, 29c,
30c, 93, 103, 132, 212, 207, 691, 709) determined by RT-PCR in
PC12 cells treated with Ngf—from left to right, respectively—for 0,
1, 3, 6, 24, 240 h; the most rightward bar of each plot represents cells
treated with Ngf for 10 days and deprived of Ngf for 24 h. Expression
levels are relative to cells not treated with Ngf. MiR expression values
were calculated by the comparative DDCt method; U6 small nucleolar
RNA (snoRNA) was used as internal control. Data represent averages
of three independent experiments along with s.e.m. P values were
calculated by one-way ANOVA followed by Tukey’s multiple
comparison test; *p \ 0.05; **p \ 0.03; ***p \ 0.01
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Table 2 Select Ngf-modulated microRNAs appear to affect relevant neuronal pathways
KEGG Pathway p value #genes #miRNAs
A
ECM-receptor interaction 9.8e-23 22 7
Axon guidance 8.6e-08 45 9
Focal adhesion 8.6e-08 60 10
Neurotrophin signaling pathway 2.6e-04 37 10
MAPK signaling pathway 5.1e-05 62 10
Gap junction 1.1e-03 20 8
Cytokine–cytokine receptor interaction 1.6e-03 45 10
ErbB signaling pathway 1.9e-03 28 10
mTOR signaling pathway 7.1e-03 17 7
TGF-beta signaling pathway 7.1e-03 23 7
Long-term depression 8.4e-03 16 7
Circadian rhythm 9.0e-03 8 6
Regulation of actin cytoskeleton 2.5e-02 45 9
KEGG Pathway REFLIST Observed p value
B
miR-21 (112 predicted targets)
MAPK signaling pathway 259 16 5.7e-06
Cytokine–cytokine receptor interaction 267 14 1.2e-05
PI3 K-Akt signaling pathway 345 12 9.0e-03
Regulation of actin cytoskeleton 214 9 7.3e-03
JAK-STAT signaling pathway 158 9 1.1e-03
Neurotrophin signaling pathway 120 9 1.6e-04
miR-29c (325 predicted targets)
PI3 K-Akt signaling pathway 345 51 5.5e-13
Focal adhesion 206 38 7.0e-13
ECM-receptor interaction 87 25 2.5e-13
MAPK signaling pathway 259 18 0.04
Regulation of actin cytoskeleton 214 17 0.02
Neurotrophin signaling pathway 120 15 5.6e-0
Axon guidance 131 14 1.5e-04
Dopaminergic synapse 130 12 0.01
miR-103 (203 predicted targets)
PI3 K-Akt signaling pathway 345 17 0.02
MAPK signaling pathway 259 14 0.02
Regulation of actin cytoskeleton 214 12 0.02
Dopaminergic synapse 130 12 5.0e-04
Wnt signaling pathway 143 11 3.2e-03
Neurotrophin signaling pathway 120 7 0.04
miR-30c (424 predicted targets)
PI3 K-Akt signaling pathway 345 28 0.04
MAPK signaling pathway 259 26 7.4e-03
Regulation of actin cytoskeleton 214 25 1.5e-03
Axon guidance 131 23 6.7e-06
Focal adhesion 206 19 0.03
Neurotrophin signaling pathway 120 19 1.6e-04
Wnt signaling pathway 143 16 0.01
Dopaminergic synapse 130 16 5.3e-03
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Table 2 continued
KEGG Pathway REFLIST Observed p value
Long-term potentiation 71 14 1.1e-04
miR-93 (245 predicted targets)
PI3 K-Akt signaling pathway 345 26 3.0e-04
MAPK signaling pathway 259 25 7.7e-06
Regulation of actin cytoskeleton 214 19 2.5e-04
Neurotrophin signaling pathway 120 17 1.6e-06
Axon guidance 131 14 2.6e-04
Focal adhesion 206 14 0.01
Wnt signaling pathway 143 13 1.7e-03
mTOR signaling pathway 60 10 5.5e-05
TGF-beta signaling pathway 81 10 6.3e-04
miR-132 (157 predicted targets)
PI3 K-Akt signaling pathway 345 20 1.3e-04
MAPK signaling pathway 259 13 5.6e-03
Axon guidance 131 13 1.1e-05
Regulation of actin cytoskeleton 214 12 3.4e-03
Focal adhesion 206 11 6.7e-03
TGF-beta signaling pathway 81 10 1.8e-05
Dopaminergic synapse 130 9 2.8e-03
Glutamatergic synapse 170 9 0.01
Neurotrophin signaling pathway 120 9 1.7e-03
miR-212 (72 predicted targets)
Axon guidance 131 4 0.04
Long-term potentiation 71 3 0.03
miR-691 (177 predicted targets)
PI3 K-Akt signaling pathway 345 16 0.01
MAPK signaling pathway 259 11 0.04
Axon guidance 131 11 6.0e-04
Focal adhesion 206 11 0.01
Wnt signaling pathway 143 8 0.02
TGF-beta signaling pathway 81 7 4.6e-03
GABAergic synapse 89 6 0.02
miR-709 (228 predicted targets)
PI3 K-Akt signaling pathway 345 21 4.5e-03
Axon guidance 131 16 8.6e-06
Focal adhesion 206 16 1.3e-03
Regulation of actin cytoskeleton 214 14 0.01
ErbB signaling pathway 88 14 1.4e-06
Wnt signaling pathway 143 12 2.7e-03
Dopaminergic synapse 130 12 1.3e-03
Cholinergic synapse 112 9 0.01
Neurotrophin signaling pathway 120 9 0.01
Long-term potentiation 71 7 8.4e-03
A KEGG Pathways affected by ten select microRNAs. Predicted targets of the ten select miRs—21, 29c, 30c, 93, 103, 132, 212, 207, 691, 709—
were collectively retrieved and mapped into the KEGG Pathway database through DIANA miR-Path software. B KEGG Pathways affected by
each of the ten select miRs. Predicted targets of each miR were retrieved by TargetScan and mapped into the KEGG Pathway database; only
pathways with p value B 0.05 were retained. Pathways relevant to nervous system and neurons were considered; mir-207 did not show nervous
system relevant pathways with statistical significance. The number of Ngf-modulated miRs targeting a given pathway and the numbers of genes
targeted in that pathway are indicated
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Ngf-modulated miRs. This indicates that Ngf may control
multiple miRs to target the same pathway.
MiR-21 is a Ngf-Modulated RNA Involved in Ngf
Signaling and Differentiation
We selected for further investigation miR-21, because it
was highly upregulated in PC12 cells from 6 h to 10 days
of Ngf treatment and strongly associated to MAPK sig-
naling pathway—a key mediator of Ngf signaling—
according to the analysis of Table 2B. These observations
suggested a role of this microRNA in Ngf signaling and
differentiation. To evaluate this hypothesis, we stably
transduced PC12 cells with a miR-21 producing lentivirus
(miR-21 cells) and a control lentivirus producing a 22-mer
RNA lacking homology to any human gene (control cells).
We measured miR-21 expression by Northern blotting and
RT-PCR: miR-21 ectopically expressing cells produced
2.8-fold more miR-21 than control cells (Fig. 3a, b). This
overexpression level is similar to the one observed in PC12
cells treated with Ngf and can therefore be considered in a
physiological range. A 20-fold overexpression of miR-21
was instead toxic to cells (not shown).
To determine whether miR-21 ectopic expression
affected PC12 cell capacity to undergo neuronal differen-
tiation in response to Ngf, we treated control and miR-21
cells for 2 days with Ngf. We evaluated the length of the
main developing axons and found that they were on aver-
age longer in cells ectopically expressing miR-21, com-
pared with control cells (Fig. 3c, d). To further support the
role of miR-21 in differentiation, we investigated the effect
of its inhibition. We transfected PC12 cells with a plasmid
expressing a miR-21 sponge (Ebert et al. 2007) and mea-
sured the length of developing axons. Figure 3e, f shows a
significant decrease of axonal length in cells expressing the
miR-21 sponge. To assess whether miR-21 may have
similar properties in primary neurons, we repeated the
experiment in dorsal root ganglia (DRG) neurons, a highly
Ngf responsive population. Dissociated DRGs were trans-
fected with the plasmid encoding a miR-21 sponge and
stimulated with Ngf for 12 h. The results show a statisti-
cally relevant decrease of axon length in cells transfected
with the miR-21 sponge compared to non-transfected cells
or to cells transfected with a plasmid encoding an EGFP
reporter only (Fig. 4a–c). Consistently with this finding,
miR-21 overexpression appeared to increase neurite size in
DRG neurons (Figure S1).
Ngf treatment of PC12 cells triggers phosphorylation of
MAPK and Akt—a key component of Pi3K signaling—
kinases, which remain phosphorylated and active for 1–3 h.
To determine whether miR-21 ectopic expression affected
Ngf signaling, we measured MAPK and Akt phosphorylation
in PC12 miR-21 and control cells upon Ngf treatment for 0
min, 10 min, and 3 h. As shown in the left panel of Figure S2,
Akt and MAPK phosphorylation in cells ectopically
expressing miR-21 was enhanced at both 10 min and 3 h of
Ngf treatment, compared with controls.
Persistent MAPK activation and Creb transcription
factor phosphorylation caused by Ngf and Bdnf signaling
mediate the expression of neurospecific genes, such as
vgf—which encodes a neuropeptide precursor protein. Vgf
expression in PC12 cells represents a differentiation mar-
ker strictly dependent on Ngf signaling. Activation of vgf
transcription occurs after 1–3 h and involves Creb binding
to a CRE (cAMP response element) in the promoter region
(Levi et al. 2004; Mandolesi et al. 2002). To determine
whether ectopic expression of miR-21 affected Vgf
expression, we treated with Ngf control PC12 cells, cells
ectopically expressing miR-21, and cells where miR-21 is
inhibited by a lentivirus encoding a miR-21 sponge, and
performed immunoblots with Vgf antibodies (Fig. 5). Cells
ectopically expressing miR-21 had a higher Vgf level than
control cells at 3 h of Ngf treatment (Fig. 5a, left panel).
Cells expressing the mir-21 sponge, instead, showed a
decreased level of Vgf (Fig. 5a, right panel). This supports
the hypothesis that miR-21 may promote expression of
neuronal differentiation markers in PC12 cells by enhanc-
ing Ngf signaling.
MiR-21 Protects PC12 Cells from Degeneration Upon
Ngf Withdrawal
Ngf has a critical role in differentiation and survival of
neuronal populations in vivo and has similar effect on
Fig. 3 MiR-21 promotes PC12 cell differentiation in response to
Ngf. a–b MiR-21 expression in PC12 cells transduced with miR-21
expressing (miR-21) or control lentivirus. a Representative Northern
blotting. b Histograms showing miR-21 expression—relative to
control cells set to a value of 1—measured by Northern blotting
(left) and real-time PCR (right). Northern blotting data are presented
as mean ± s.e.m. of two independent experiments; U2 snoRNA was
used as loading control. Real-time PCR data are presented as
mean ± s.e.m. of triplicate samples, from two biological replicates;
U6 snoRNA was used as loading control. c–d Neurite length of PC12
cells ectopically expressing, or not, miR-21 and stimulated for 2 days
with Ngf. c Immunofluorescence staining of a-tubulin. Scale bar
30 lm. d Histogram showing the average length of axons, expressed
in lm. Data are represented as means ± s.e.m. of triplicate determi-
nations of ten random fields in three independent experiments.
*P value B0.05, according to Student’s t test. e–f Neurite length of
PC12 cells transfected with a miR-21 sponge plasmid—harboring a
destabilized EGFP with several miR-21 binding sites in the 30
untranslated region –, stimulated for 2 days with Ngf, and fixed with
4 % PFA. e Photomicrographs. The green color represents EGFP;
scale bar 30 lm. f The histogram shows neurite mean length, express
in lm; data are represented as means ± s.e.m. of triplicate determi-
nations of ten random fields in three independent experiments.
*P value B0.05, according to Student’s t test
c
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PC12 cells in culture. In the presence of Ngf, these cells
undergo mitotic arrest and progressive differentiation into
cholinergic neurons that develop a network of nerve fibers
(Greene 1978; Greene and Tischler 1976). Ngf is sufficient
to preserve the differentiated state of PC12 cells, even in
the absence of serum in the growth medium. In fully
Neuromol Med (2014) 16:415–430 423
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differentiated PC12 cells deprived of Ngf, the neurite
network quickly collapses and cells die by apoptosis
(Mesner et al. 1995). This process—associated to increased
expression and processing of amyloid precursors protein
App, leading to overproduction of amyloid Ab peptides—
bears some resemblance to the degenerative process
occurring in AD (Matrone et al. 2008b; Zhang et al. 2011).
Because miR-21 enhances Ngf signaling and differentia-
tion of PC12 cells (Figs. 3, 4, 5), we asked whether it might
affect PC12 cell neuronal degeneration and death observed
upon Ngf deprivation. To evaluate this possibility, PC12
cells—ectopically expressing or not miR-21—were treated
with Ngf for 10 days to achieve full neuronal differentia-
tion and then deprived of Ngf for 24, 48, and 72 h. We
examined cell morphology upon staining with a-tubulin
antibody (Fig. 6a) and investigated cell survival by cell
count, trypan blue exclusion assay, and DAPI staining
(Fig. 6b, c). Control cells displayed a drastic reduction of
the number of nuclei and a strong retraction of neurite
arborization from 24 to 72 h after Ngf deprivation. These
phenomena were very attenuated in PC12 cells ectopically
expressing miR-21, which presented a remarkable reduc-
tion of degeneration of the neuritic network upon depri-
vation of Ngf (Fig. 6a). Concomitantly, cell survival in
PC12/miR-21 cells was strongly increased at 24, 48, and
72 h of Ngf deprivation (Fig. 6b, c). These assays dem-
onstrate a protective role of microRNA-21 against cell
death and neuritic degeneration in differentiated PC12 cells
deprived of Ngf. Following Ngf deprivation, terminally
differentiated PC12 cells show an increase in the amount of
App protein (Matrone et al. 2008b). We measured App
levels by immunoblotting in PC12 miR-21 and control
cells—terminally differentiated by 10 days of treatment
with Ngf—at different times after Ngf removal from the
culture medium: 10 min, 30 min, 6 and 24 h (Fig. 7). PC12
miR-21 cells—either untreated or treated for 10 days with
Ngf—had App levels slightly higher than control cells.
App levels in control cells strongly increased starting at
10 min after Ngf removal. In cells ectopically expressing
miR-21, instead, the amount of App slightly decreased
following Ngf deprivation. These data indicate that miR-21
may restrain App production.
Discussion
MicroRNAs are involved in fine-tuning gene expression in
fundamental cellular processes (Kosik 2006). We identify a
variety of microRNAs whose expression is modulated by
Ngf in the course of PC12 cell differentiation. Promoters of
many of them are enriched in Creb binding sites, an indi-
cation that Ngf may regulate their expression via Creb.
Predicted targets of miRs modulated by Ngf are strongly
enriched of MAPK and Pi3 K/Akt signaling components
(Table 1). This was confirmed by target analysis of ten
selected Ngf-modulated microRNAs (Table 2). Therefore,
it appears that the microRNAs we have identified may
participate in tuning neurotrophin signaling. Besides
MAPK and Akt signaling, Ngf-modulated miRs seem to
preferentially target other neuronal relevant pathways such
as axon guidance and regulation of actin cytoskeleton,
focal adhesion and GAP junctions, glutamergic, dopami-
nergic, cholinergic, and GABA-ergic synapses, long-term
depression, circadian rhythms, mental disorders, and AD
(Tables 1, 2). This is also evident from the analysis of
single selected miRs: miR-21, miR-29c, miR-30c, miR-93,
miR-103, miR-132, miR-212, miR-207, miR-691, and
miR-709. MiR-21 upregulation by Ngf (Fig. 2 and Table
S1) is in agreement with a previous report (Mullenbrock
et al. 2012). Ngf may stimulate miR-21 expression through
the AP-1 transcription factor, which is preferentially
induced in PC12 cells and is known to upregulate miR-21
(Mullenbrock et al. 2012; Talotta et al. 2009). Validated
targets of miR-21 include the apoptosis regulator PDCD4,
the negative regulators of tyrosine kinase receptor signal-
ing Sprouty1-2 and Pten, and the inhibitor of neurite
growth Rtn4—all implicated in neurotrophin signaling.
MiR-29c targets b-secretase 1 (Bace1)—a protein involved
in App processing and mutated in familial AD (Zong et al.
2011)—and is downregulated in Huntington’s disease
models (Lee et al. 2011); miR-30c is modulated by tyrosine
kinase receptors and targets Bdnf mRNA (Mellios et al.
2008) as well as mRNAs encoding proteins involved in AD
(App), neurotrophin signaling, and axon guidance; miR-93
has been implicated in neurogenesis and control of App
protein level (Brett et al. 2008, Maes et al. 2009); miR-103
targets mRNAs encoding ID2—an inhibitor of neuronal
differentiation (Annibali et al. 2012)—and neurofibromin,
involved in a disease characterized by learning disabilities
(Paschou et al. 2012); little is known about miR-207; miR-
691 is expressed at relatively high levels in retina (Loscher
et al. 2008); miR-709 is upregulated by stress in hippo-
campus and prefrontal cortex (Babenko et al. 2012) and it
is a regulator of the injury response in the peripheral ner-
vous system (Adilakshmi et al. 2012); mir-132 and miR-
212 have been implicated in mechanisms of synaptic
plasticity, drug addiction, mental diseases, and neurologi-
cal disorders (Wanet et al. 2012). All this indicates that
neurotrophins may affect a variety of nervous system rel-
evant processes by controlling expression of multiple
miRs.
On the basis of our results, we propose miR-21 as
positive regulator of Ngf signaling. MiR-21 augments
MAPK and Akt phosphorylation in response to Ngf and
contributes to an increased expression of Vgf, a gene
specifically induced by neurotrophins (Figs. 5 and S2).
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MiR-21 was shown to enhance MAPK and Akt signaling
by targeting Pten and Spry2 (Sprouty 2), negative regula-
tors of tyrosine kinase receptor signaling (Mei et al. 2012;
Hatley et al. 2010; Hausott et al. 2009). Sprouty 2 and 4, in
particular, negatively modulate TrkA and TrkB signaling
(Alsina et al. 2012). The view of miR-21 as enhancer of
Ngf signaling is consistent with its capability of stimulating
PC12 cell differentiation in response to Ngf (Fig. 3),
probably through TrkA receptor signaling. Coherently with
this finding, miR-21 inhibition hampers neurite outgrowth
of DRG neurons in response to Ngf, while ectopic
expression of mR-21 seems to increase nerve fiber growth
(Figs. 4 and S1). This evidence is indicative of a possible
role of miR-21 on axonal development and is concordant
with data showing that nerve fiber outgrowth in DRGs is
enhanced by miR-21 overexpression (Strickland et al.
2011). In other cell types, instead, expression of miR-21
following activation of different tyrosine kinase receptors
supports proliferation rather than differentiation (Krichev-
sky and Gabriely 2009). This may be explained by the
different role of ERK/MAPK and Akt signaling in different
cellular contexts. MAPK pathway activation in response to
neurotrophins is known to promote neuronal differentia-
tion, whereas it promotes proliferation in response to
stimuli like epidermal growth factor or interleukin-6.
Analogously, miR-21 knock down either enhances or
suppresses cancer cell growth, according to cell type (Pa-
pagiannakopoulos et al. 2008; Wang et al. 2009).
Since Ngf is crucial for survival and nerve fiber arbor-
ization in PC12 cells, an enhancement of Ngf signaling by
miR-21 may as well explain its anti-neurodegenerative
properties, the most striking of our results (Figs. 6, 7). A
defect of neurotrophin signaling has been involved in AD
and other neurodegenerative diseases. Such a neuropro-
tective role of miR-21 is coherent with recent evidence:
miR-21 protects neurons from ischemic death (Buller et al.
2010), it is induced by axotomy and promotes axon growth
(Strickland et al. 2011), regulates the response of astrocytes
following spinal cord injury (Bhalala et al. 2012) in
microglia, targets the apoptotic inducer Fas ligand (FasL),
and has a neuroprotective role (Zhang et al. 2012).
In conclusion, our findings identify an additional mecha-
nism for sustaining neurotrophin signaling and indicate that
altered regulation of miR-21 and possibly other neurotrophin-
modulated microRNAs may contribute to neurodegeneration.
Materials and Methods
Cell Culture
PC12 cells were cultured in RPMI medium containing
10 % horse serum (HS) and 5 % fetal bovine serum (FBS)
in a CO2 humidified incubator at 37 C. Mouse salivary
gland ß-Ngf was kindly provided by Bioway Company,
China. Lyofilized, sterile samples of 17 lg each were
dissolved in 1 ml sterile 0.9 % NaCl and kept at 4 C until
use. Ngf was used at a concentration of 100 ng/ml. Dif-
ferentiation was achieved by treating cells with Ngf for
10 days, as described (Matrone et al. 2008b). In the Ngf
deprivation experiments, cells were washed three times
with PBS, once with serum-free medium, and placed in
serum-free media without Ngf (Matrone et al. 2008b).
Dorsal root ganglia (DRGs) were collected from Wistar
rats at P0 (postnatal day 0) to P5 in PBS, digested with
0.02 % trypsin for 30 min at 37 C, and further dissociated
with a Pasteur pipette. Approximately 100,000/200,000 cells
were plated on slides coated with poly-D-lysine and cultured
in DMEM F12 plus 10 % FBS serum without Ngf.
Expression Plasmids
To obtain the miR-21 expressing lentiviral vector pRRL-
21, a region of about 300 bp containing the miR-21 DNA
sequence was amplified from Jurkat cells genomic DNA
with cgcgcgcggaccggatcaaatcctgcctgactgt (forward) and
cgcgcgcgtagctgccaccagacagaaggacc (reverse) primers and
cloned into RsrI and NheI sites of the lentiviral vector
#1074.1071.hPGK.GFP.WPRE.mhCMV.dNgfR.SV40PA,
kindly provided by Prof Luigi Naldini (TIGET, Milan).
The pRRL-control vector was obtained by substituting the
miR-21 precursor fragment (RsrI–NheI) with a sequence
encoding a hairpin yielding a 22-mer RNA designed to lack
homology to any human gene. The miR-21 sponge
expression plasmid CMV-d2eGFP-21 was purchased by
Addgene (plasmid #21972); it incorporates several miR-21
binding sequences in the 3’UTR of a destabilized EGFP
gene (Ebert et al. 2007). The miR-21 sponge lentiviral
plasmid was obtained by replacing the miR-233 target
sequence with the miR-21 sponge, in the lentiviral vector
described in Gentner et al. 2009.
Cell Transfection and Lentivirus Infection
PC12 cells were plated on poly-D-lysine and transfected
with plasmid DNA by using Lipofectamine LTX plus
(Invitrogen) following the manufacturer’s instructions.
24 h later, cells were stimulated with Ngf in RPMI medium
containing 5 % HS and 2,5 % FBS. After 48 h, cells were
fixed with 4 % paraformaldehyde and examined by a Ni-
kon Eclipse TE2000-E microscope. DRGs were dissected
and plated on poly-D-lysine in the absence of Ngf; the day
after, DRGs were transfected with plasmid CMV-d2eGFP-
21 and plasmid encoding EGFP as control by means of
lipofectamine LTX plus (Invitrogen), following the
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manufacturer’s instructions. After 4 h, cells were stimu-
lated with 100 ng/ml Ngf for 12 h. Neurite length in PC12
cells and DRG neurons was evaluated by Fiji software
(http://fiji.sc/Fiji). Lentivirus was prepared and cell infec-
tions were performed as described (Annibali et al. 2012).
Northern Blotting
Northern blotting was carried out as described (Annibali
et al. 2012). Total RNA was extracted with TRIzol Reagent
(Life Technologies) according to manufacturer’s instruc-
tions, fractionated by 15 % poly-acrylamide gel electro-
phoresis in 1X TBE, 7M urea and transferred onto
Amersham Hybond-NX nylon membrane (GE Healthcare).
Membranes were hybridized to 32P-labeled DNA
oligonucleotides complementary to the sequence of mature
miR-21 TCAACATCAGTCTGATAAGCTA and U2 small
nucleolar RNA (snoRNA) GCAGGGGCCATGCTAATCT
TCTCTGTATCG, used to normalize expression levels.
Real-Time PCR
Quantitative real-time PCR (RT-PCR) was performed using
the miScript SYBR Green PCR Kit in 96-well plates accord-
ing to the manufacturer’s instructions. Each 20 ll reaction
contained 2.5 ng template cDNA, 2 ll universal primer, and
2 ll miR specific primer (from Qiagen) or U6 snoRNA primer
as control. Real-time PCR reactions were performed by an
Fig. 4 miR-21 inhibition affect neurite outgrowth in DRG cells. a,
b Immunofluorescence staining. a Control, untransfected DRG cells,
b DRG cells transfected with an EGFP encoding plasmid (control
EGFP) and with the plasmid encoding the miR-21 sponge. Blue
Hoechst staining; red ß-III-tubulin; green GFP. Scale bar 15.5 lm.
c The histogram shows the mean length of neurites express in lm.
Data are represented as means ± s.e.m. of triplicate determinations
of ten random fields in four independent experiments. A total of 169
cells were counted for the not transfected control, a total of 133 cells
were counted for EGFP control, and a total of 170 cells were counted
for the miR-21 sponge. P values were calculated by one-way
ANOVA followed by Tukey’s multiple comparison test; ***p value
B0.01
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Applied Biosystem 7500 apparatus. Expression data were
calculated by 7500 software v2.0.5 (Applied Biosystems)
according to the DDCt method and expressed as relative
quantities after normalization to U6 level.
Microarray Analysis
Before proceeding with microarray profiling, the efficacy
of Ngf was checked by RT-PCR expression analysis of
PC3, a known Ngf immediate-early responsive gene (data
not shown). RNA was extracted with TRIzol and 5 lg
RNA from each sample were labeled with Hy5TM and
Hy3TM fluorescent labels using the miRCURYTM LNA
Array power labeling kit (Exiqon, Denmark), according to
the procedure described by the manufacturer. Hy5TM-
labeled samples and Hy3TM-labeled reference RNA sample
were mixed pair-wise and hybridized to the miRCURYTM
LNA Array version 11.0 (Exiqon, Denmark), which con-
tains capture probes targeting 514 unique miRs from
human, mouse, and rat registered in miRBASE version
12.0, and spike-in controls. The hybridization was carried
out as recommended by the vendor. After hybridization,
the microarray slides were scanned using a Perkin-Elmer
Scan Array and images analyzed by the GenePix Pro 6.0
program. Analysis of the scanned slides indicated
successful labeling of RNAs as evidenced by the signal
intensities of all capture probes for the control spike-in
oligonucleotides. For each slide, spots with signal to
background ratio below 1.5 and flagged spots were filtered
out. Systematic bias in the data was removed by applying
the LOWESS normalization. To establish the significance
of observed regulation for each miR, Student’s t test was
used and the p values were corrected for multiple com-
parisons. Finally, miRs with a p value less than 0.05 and a
FC greater than 1.7 or less than -1.7 (FC at least 1.7 in
absolute value) were considered. Heat maps were gener-
ated by two-way hierarchical clustering. Microarray data
are deposited in GEO and accessible at the record #
GSE46827.
Bioinformatics Analysis
TargetScan (6.2; http://targetscan.org/) and DIANA mi-
croT (http://diana.cslab.ece.ntua.gr/microT/) software was
used to predict microRNA targets. Targets were investi-
gated through DIANA mir-Path (http://diana.cslab.ece.
ntua.gr/) and KEGG Pathway, containing over 20,900
annotated human genes (www.genome.jp/kegg/pathway.
html). Creb binding sites were investigated via JASPAR
(http://jaspar.genereg.net/).
Fig. 5 Vgf induction in PC12
cells is affected by miR-21
expression. a Vgf
immunoblotting in control PC12
cells and cells ectopically
expressing miR-21 (left) or a
miR-21 sponge (right), treated
with Ngf for 0 and 3 h.
b Densitometric analyses of the
immunoblots—normalized to
the actin loading control—of
three independent experiments.
Data are presented as
mean ± s.e.m. P values were
calculated by one-way ANOVA
followed by Tukey’s multiple
comparison test;
**p value B0.01
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Immunoblotting and Immunohistochemistry
Whole-cell protein extracts were prepared from cells
lysed in RIPA buffer. Samples were separated through
SDS PAGE gels, transferred to Hybond ECL mem-
branes (GE Healthcare), and treated with appropriate
antibodies. Staining was performed by the SuperSignal
Chemiluminescent Substrate from Pierce. ImageJ soft-
ware (http://rsbweb.nih.gov/ij/) was used for densito-
metric analysis; western blot quantification was
normalized against loading controls. Immunohisto-
chemical detection was performed as described (Anni-
bali et al. 2012).
Antibodies used: phospho-Akt(Ser473) and phospho-
p44/42 MAPK (ERK1/2) (Thr202/Tyr204) antibodies were
from Cell Signaling, Vgf antibody [24] was kindly pro-
vided by A. Levi, monoclonal anti-b-Actin–peroxidase
clone Ac-15 (A3854) and anti-a-Tubulin (T6199) were
from Sigma, beta III tubulin antibody was from Abcam,
and mouse monoclonal anti-App (22C11) from Millipore.
Fig. 6 MiR-21 prevents degeneration of differentiated PC12 cells
upon deprivation of Ngf. a Immunofluorescence staining of a-tubulin
in PC12 cells, differentiated for 10 days with Ngf (10 d Ngf) and then
deprived of Ngf for 24, 48, and 72 h. b Trypan blue exclusion assay.
The histogram indicates percentages of dead cells, at 24 and 48 h
after deprivation of Ngf. Data are represented as means ± s.e.m. of
four independent experiments. c Cell viability was evaluated by
DAPI staining and counting of intact nuclei. Data are represented
as means ± s.e.m. of triplicate determinations of ten random fields
in three independent experiments. P values were calculated by
one-way ANOVA followed by Tukey’s multiple comparison test.
*P value B0.05
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Horseradish peroxidase secondary antibodies were from
Chemicon and Protein A peroxidase from Sigma.
Statistical Analysis
Values are expressed as mean ± s.e.m. Statistical analyses
were performed by Student’s t test, hypergeometric func-
tion, and ANOVA, followed by the Newman–Keuls or
Tukey’s multiple comparison tests. Statistical significance
was accepted at the 95 % confidence level (p value B0.05).
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